Table 2

Distribution of cervical atypia risk factors by interval between menarche and age at the start of OC use or age at the FSI in young adult women followed up for 4 years

CategoryInterval between menarche and age at the start of OC useInterval between menarche and the FSI
Interval <3 yearsInterval ≥3 yearsInterval <3 yearsInterval ≥3 years
(n=192)(n=675)(n=302)(n=566)
n/Mean (%/SD)n/Mean (%/SD)n/Mean (%/SD)n/Mean (%/SD)
Chlamydia trachomatis39 (20.3)59 (8.7)54 (18.0)44 (7.8)
HPV 1655 (28.7)142 (21.1)97 (32.2)100 (17.8)
HPV 1835 (18.2)83 (12.3)47 (15.6)71 (12.5)
HPV 16/1869 (35.9)190 (28.2)115 (38.2)144 (25.4)
Smoking
 Never84 (43.8)405 (60.4)134 (44.8)356 (63.0)
 Past smoker22 (11.4)69 (10.2)37 (12.4)54 (9.6)
 Present smoker86 (44.8)197 (29.4)128 (42.8)155 (27.4)
Age at menarche13.4 (1.2)12.2 (1.1)13.1 (1.3)12.1 (1.1)
Age at FSI14.7 (1.2)16.3 (1.9)14.6 (1.2)16.7 (1.9)
Age at start of OC use14.9 (1.2)16.9 (1.7)15.3 (1.3)17.1 (1.7)
Lifetime number of partners
 001 (0.2)01 (0.2)
 111 (5.7)119 (17.6)14 (4.6)116 (20.5)
 2–446 (24.0)230 (34.1)73 (24.2)204 (36.0)
 5–969 (36.0)163 (24.2)98 (32.5)134 (23.7)
 >1066 (34.4)162 (24.0)117 (38.7)111 (19.6)
  • FSI, first sexual intercourse; HPV, human papillomavirus; OC, oral contraceptive.